Vitamin D receptor activator and prevention of cardiovascular events in hemodialysis patients—rationale and design of the Japan Dialysis Active Vitamin D (J-DAVID) trial
Crossref DOI link: https://doi.org/10.1186/s41100-016-0029-z
Published Online: 2016-04-25
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Shoji, Tetsuo
Inaba, Masaaki
Nishizawa, Yoshiki
Funding for this research was provided by:
The Kidney Foundation, Japan (No number given, No number given)
